4.7 Article

Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue

Journal

AGING CELL
Volume 19, Issue 10, Pages -

Publisher

WILEY
DOI: 10.1111/acel.13219

Keywords

adipose tissue; aging; frailty index; immune checkpoint; inflammation; macrophage; mouse; VSIG4

Funding

  1. Everon Biosciences
  2. NIH [R37AG13925, P01AG 62413]
  3. Connor Group
  4. Noaber Foundation

Ask authors/readers for more resources

Adipose tissue is recognized as a major source of systemic inflammation with age, driving age-related tissue dysfunction and pathogenesis. Macrophages (M phi) are central to these changes yet adipose tissue M phi (ATMs) from aged mice remain poorly characterized. To identify biomarkers underlying changes in aged adipose tissue, we performed an unbiased RNA-seq analysis of ATMs from young (8-week-old) and healthy aged (80-week-old) mice. One of the genes identified, V-set immunoglobulin-domain-containing 4 (VSIG4/CRIg), encodes a M phi-associated complement receptor and B7 family-related immune checkpoint protein. Here, we demonstrate thatVsig4expression is highly upregulated with age in perigonadal white adipose tissue (gWAT) in two mouse strains (inbred C57BL/6J and outbred NIH Swiss) independent of gender. The accumulation of VSIG4 was mainly attributed to a fourfold increase in the proportion of VSIG4(+)ATMs (13%-52%). In a longitudinal study, VSIG4 expression in gWAT showed a strong correlation with age within a cohort of male and female mice and correlated strongly with physiological frailty index (PFI, a multi-parameter assessment of health) in male mice. Our results indicate that VSIG4 is a novel biomarker of aged murine ATMs. VSIG4 expression was also found to be elevated in other aging tissues (e.g., thymus) and was strongly induced in tumor-adjacent stroma in cases of spontaneous and xenograft lung cancer models. VSIG4 expression was recently associated with cancer and several inflammatory diseases with diagnostic and prognostic potential in both mice and humans. Further investigation is required to determine whether VSIG4-positive M phi contribute to immunosenescence and/or systemic age-related deficits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients

Fangyi Gu, Mark K. Farrugia, William D. Duncan, Yingdong Feng, Alan D. Hutson, Nicolas F. Schlecht, Elizabeth A. Repasky, Marina P. Antoch, Austin Miller, Alexis Platek, Mary E. Platek, Austin J. Iovoli, Anurag K. Singh

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Article Oncology

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

Lioubov Korotchkina, Denis Kazyulkin, Pavel G. Komarov, Alex Polinsky, Ekaterina L. Andrianova, Sangeeta Joshi, Mahima Gupta, Slavoljub Vujcic, Eugene Kononov, Ilia Toshkov, Yuan Tian, Peter Krasnov, Mikhail Chernov, Jean Veith, Marina P. Antoch, Shiloh Middlemiss, Klaartje Somers, Richard B. Lock, Murray D. Norris, Michelle J. Henderson, Michelle Haber, Olga B. Chernova, Andrei Gudkov

LEUKEMIA (2020)

Article Cell Biology

Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice

Mikolaj Ogrodnik, Shane A. Evans, Edward Fielder, Stella Victorelli, Patrick Kruger, Hanna Salmonowicz, Bettina M. Weigand, Ayush D. Patel, Tamar Pirtskhalava, Christine L. Inman, Kurt O. Johnson, Stephanie L. Dickinson, Azucena Rocha, Marissa J. Schafer, Yi Zhu, David B. Allison, Thomas von Zglinicki, Nathan K. LeBrasseur, Tamar Tchkonia, Nicola Neretti, Joao F. Passos, James L. Kirkland, Diana Jurk

Summary: Clearing senescent cells, either through drug treatment or senolytic cocktail, has been shown to improve cognitive function, providing proof-of-concept for senolytic interventions as a potential therapeutic avenue for alleviating age-associated cognitive impairment.

AGING CELL (2021)

Article Urology & Nephrology

Mechanisms of vascular dysfunction in the interleukin-10-deficient murine model of preeclampsia indicate nitric oxide dysregulation

Hajrunisa Cubro, Karl A. Nath, Sonja Suvakov, Oscar Garcia-Valencia, Santosh Parashuram, Wendy M. White, Tracey L. Weissgerber, Meryl C. Nath, Natasa M. Milic, Fernando Sontag, Livius D'Uscio, Yi Zhu, James L. Kirkland, Tamar Tchkonia, Mariam P. Alexander, Reade A. Quinton, Zvonimir S. Katusic, Joseph P. Grande, Vesna D. Garovic

Summary: In the IL-10-/-sPE murine model, aortic contractions to phenylephrine were significantly augmented compared to wild type normotensive mice, indicating impaired endothelium-dependent and to a lesser extent, endothelium-independent relaxation. The results highlight the role of IL-10 deficiency in dysregulation of the cyclooxygenase pathway and vascular dysfunction in the IL-10-/-sPE murine model of preeclampsia, suggesting a possible contribution of nitric oxide dysregulation.

KIDNEY INTERNATIONAL (2021)

Article Multidisciplinary Sciences

An aged immune system drives senescence and ageing of solid organs

Matthew J. Yousefzadeh, Rafael R. Flores, Yi Zhu, Zoe C. Schmiechen, Robert W. Brooks, Christy E. Trussoni, Yuxiang Cui, Luise Angelini, Kyoo-A Lee, Sara J. McGowan, Adam L. Burrack, Dong Wang, Qing Dong, Aiping Lu, Tokio Sano, Ryan D. O'Kelly, Collin A. McGuckian, Jonathan I. Kato, Michael P. Bank, Erin A. Wade, Smitha P. S. Pillai, Jenna Klug, Warren C. Ladiges, Christin E. Burd, Sara E. Lewis, Nicholas F. LaRusso, Nam V. Vo, Yinsheng Wang, Eric E. Kelley, Johnny Huard, Ingunn M. Stromnes, Paul D. Robbins, Laura J. Niedernhofer

Summary: Researchers found that aged immune system could lead to attrition and senescence of specific immune cell populations, driving systemic ageing.

NATURE (2021)

Article Geriatrics & Gerontology

Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era

Brandon P. Verdoorn, Tamara K. Evans, Gregory J. Hanson, Yi Zhu, Larissa G. P. Langhi Prata, Robert J. Pignolo, Elizabeth J. Atkinson, Erin O. Wissler-Gerdes, George A. Kuchel, Joan B. Mannick, Stephen B. Kritchevsky, Sundeep Khosla, Stacey A. Rizza, Jeremy D. Walston, Nicolas Musi, Lewis A. Lipsitz, Douglas P. Kiel, Raymond Yung, Nathan K. LeBrasseur, Ravinder J. Singh, Teresa McCarthy, Michael A. Puskarich, Laura J. Niedernhofer, Paul D. Robbins, Matthew Sorenson, Tamara Tchkonia, James L. Kirkland

Summary: Senescent cells (SnCs), which are metabolically active and resistant to apoptosis, increase with age and chronic diseases, making individuals more susceptible to SARS-CoV-2 complications. Senolytic agents, like Fisetin, selectively target and eliminate SnCs, showing promise in delaying or preventing multiple disorders. Clinical trials are underway to investigate the impact of senolytics on decreasing SARS-CoV-2 progression and morbidity in older adults, with logistical challenges considered for conducting trials in long-term care settings.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Article Multidisciplinary Sciences

Senolytics reduce coronavirus-related mortality in old mice

Christina D. Camell, Matthew J. Yousefzadeh, Yi Zhu, Larissa G. P. Langhi Prata, Matthew A. Huggins, Mark Pierson, Lei Zhang, Ryan D. O'Kelly, Tamar Pirtskhalava, Pengcheng Xun, Keisuke Ejima, Ailing Xue, Utkarsh Tripathi, Jair Machado Espindola-Netto, Nino Giorgadze, Elizabeth J. Atkinson, Christina L. Inman, Kurt O. Johnson, Stephanie H. Cholensky, Timothy W. Carlson, Nathan K. LeBrasseur, Sundeep Khosla, M. Gerard O'Sullivan, David B. Allison, Stephen C. Jameson, Alexander Meves, Ming Li, Y. S. Prakash, Sergio E. Chiarella, Sara E. Hamilton, Tamara Tchkonia, Laura J. Niedernhofer, James L. Kirkland, Paul D. Robbins

Summary: The research demonstrates that cellular senescence plays a critical role in pathogen infections, with aging mice experiencing increased senescence and inflammation after exposure to pathogens. Targeting cellular senescence can significantly reduce mortality and inflammatory markers.

SCIENCE (2021)

Article Cell Biology

Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53

Natalia Fedtsova, Elena A. Komarova, Kellee F. Greene, Liliya R. Novototskaya, Ivan Molodtsov, Craig M. Brackett, Evguenia Strom, Anatoli S. Gleiberman, Alexander N. Shakhov, Andrei V. Gudkov

Summary: The success of bone marrow transplantation depends on p53-mediated protection of critical cells in the bone marrow stroma, as it drives the apoptotic death of hematopoietic cells and protects stromal cells essential for functionality. This study reveals a dual positive role of p53 in BMT by comparing the structural changes in the bone marrow stroma of mice with different p53 statuses.

CELL DEATH & DISEASE (2021)

Article Medicine, General & Internal

Epigenetic and senescence markers indicate an accelerated ageing-like state in women with preeclamptic pregnancies

Sonja Suvakov, Ranine Ghamrawi, Hajrunisa Cubro, Haitao Tu, Wendy M. White, Yvonne S. Butler Tobah, Natasa M. Milic, Joseph P. Grande, Julie M. Cunningham, Fouad T. Chebib, Larissa G. P. Langhi Prata, Yi Zhu, Tamara Tchkonia, James L. Kirkland, Karl A. Nath, Aleksandar Milosavljevic, Vesna D. Garovic

Summary: Preeclamptic women experience accelerated epigenetic ageing and higher levels of senescence-related factors. Treatment with dasatinib rescues angiogenic potential of mesenchymal stem cells from preeclamptic pregnancies, promoting angiogenesis.

EBIOMEDICINE (2021)

Editorial Material Medicine, General & Internal

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Utkarsh Tripathi, Selim Chaib, Erin O. Wissler Gerdes, Kelly A. Hogan, Yi Zhu

EBIOMEDICINE (2021)

Article Medicine, General & Internal

Orally-active, clinically-translatable senolytics restore a-Klotho in mice and humans

Yi Zhu, Larissa G. P. Langhi Prata, Erin O. Wissler Gerdes, Jair Machado Espindola Netto, Tamar Pirtskhalava, Nino Giorgadze, Utkarsh Tripathi, Christina L. Inman, Kurt O. Johnson, Ailing Xue, Allyson K. Palmer, Tingjun Chen, Kalli Schaefer, Jamie N. Justice, Anoop M. Nambiar, Nicolas Musi, Stephen B. Kritchevsky, Jun Chen, Sundeep Khosla, Diana Jurk, Marissa J. Schafer, Tamar Tchkonia, James L. Kirkland

Summary: This study demonstrates that targeting senescent cells can increase a-Klotho levels in mice and humans, suggesting a potential therapeutic avenue for enhancing a-Klotho. Removing senescent cells can restore a-Klotho expression, offering a translational feasible strategy for developing orally-active small molecule interventions. Urinary a-Klotho may also serve as a useful biomarker for monitoring senolytic clinical trials.

EBIOMEDICINE (2022)

Article Multidisciplinary Sciences

Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance

Xu Zhang, Vesselina M. Pearsall, Chase M. Carver, Elizabeth J. Atkinson, Benjamin D. S. Clarkson, Ethan M. Grund, Michelle Baez-Faria, Kevin D. Pavelko, Jennifer M. Kachergus, Thomas A. White, Renee K. Johnson, Courtney S. Malo, Alan M. Gonzalez-Suarez, Katayoun Ayasoufi, Kurt O. Johnson, Zachariah P. Tritz, Cori E. Fain, Roman H. Khadka, Mikolaj Ogrodnik, Diana Jurk, Yi Zhu, Tamara Tchkonia, Alexander Revzin, James L. Kirkland, Aaron J. Johnson, Charles L. Howe, E. Aubrey Thompson, Nathan K. LeBrasseur, Marissa J. Schafer

Summary: The authors discovered that proinflammatory senescent myeloid cells may recruit peripheral immune cells in the aged mouse brain. Their findings suggest that senescent cell clearance could be a strategy to counter aged brain inflammation and cognitive decline. This study reveals the identities of senescent cells in the aged brain and how they exert adverse influence.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors

Ksenia A. Novototskaya-Vlasova, Nickolay S. Neznanov, Ivan Molodtsov, Brandon M. Hall, Mairead Commane, Anatoli S. Gleiberman, Jayne Murray, Michelle Haber, Murray D. Norris, Katerina I. Leonova, Andrei V. Gudkov

Summary: Activation of endogenous retrotransposons in cancer cells contributes to tumor genomic instability. Inhibition of retrotranspositions with nucleoside reverse transcriptase inhibitor stavudine (STV) extended progression-free survival in mouse cancer models following initial complete response to chemotherapy. Moreover, STV reduced the frequency of drug-resistant cells and reversed drug resistance by inhibiting NF-KB activity and reducing the constitutive activity of interferon type I and NF-KB pathways.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Medicine, Research & Experimental

Local senolysis in aged mice only partially replicates the benefits of systemic senolysis

Joshua N. Farr, Dominik Saul, Madison L. Doolittle, Japneet Kaur, Jennifer L. Rowsey, Stephanie J. Vos, Mitchell N. Froemming, Anthony B. Lagnado, Yi Zhu, Megan Weivoda, Yuji Ikeno, Robert J. Pignolo, Laura J. Niedernhofer, Paul D. Robbins, Diana Jurk, Joao F. Passos, Nathan K. LeBrasseur, Tamara Tchkonia, James L. Kirkland, David G. Monroe, Sundeep Khosla

Summary: Clearing senescent cells can prevent age-related pathologies, including bone loss. Local senolysis of senescent osteocytes prevents age-related bone loss in the spine, while systemic senolysis prevents bone loss in both the spine and femur, improving bone formation and reducing osteoclast and marrow adipocyte numbers. Transplanting senescent cells induces bone loss and senescence in distant host osteocytes.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Medicine, Research & Experimental

Cellular senescence: a key therapeutic target in aging and diseases

Lei Zhang, Louise E. Pitcher, Matthew J. Yousefzadeh, Laura J. Niedernhofer, Paul D. Robbins, Yi Zhu

Summary: Cellular senescence is a key factor in aging and age-related diseases, and targeting senescent cells has shown promise in preventing tissue damage and promoting tissue repair and regeneration.

JOURNAL OF CLINICAL INVESTIGATION (2022)

No Data Available